Emcure Pharmaceuticals Announcements
Appointment of Independent Director of the Company.
09 Mar, 2026 | 01:29pm • Source: BSE
Outcome of Board Meeting held on March 09, 2026.
09 Mar, 2026 | 01:08pm • Source: BSE
Press Release titled "Emcure Pharmaceuticals and Roche sign Distribution Agreement to strengthen Nephrology and Transplant Care in India
02 Mar, 2026 | 02:47pm • Source: BSE
Investor Presentation for Investor Conferences, to be attended by Officials of the Company, on February 23, 2026 and February 24, 2026.
20 Feb, 2026 | 06:24pm • Source: BSE
Transcript of Earnings Call - Q3 FY26
10 Feb, 2026 | 06:00pm • Source: BSE
Audio recording of Earnings Call - Q3 FY26
04 Feb, 2026 | 06:35pm • Source: BSE
Disclosure under Regulation 30(5) of the SEBI Listing Regulations intimating about authorising Key Managerial Personnel of the Company for the purpose of determining the materiality...
04 Feb, 2026 | 03:07pm • Source: BSE
Re-appointment of Independent Directors of the Company.
04 Feb, 2026 | 02:29pm • Source: BSE
Appointment of Ms. Amruta Jana Yangalwar as Company Secretary and Compliance Officer of the Company.
04 Feb, 2026 | 02:08pm • Source: BSE
Unaudited Financial Results (Consolidated and Standalone) for the quarter and nine months ended December 31, 2025
04 Feb, 2026 | 01:40pm • Source: BSE
Outcome of Board Meeting held on February 04, 2026.
04 Feb, 2026 | 01:32pm • Source: BSE
Intimation for Earnings Call - Q3 FY26
22 Jan, 2026 | 04:19pm • Source: BSE
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and...
22 Jan, 2026 | 04:05pm • Source: BSE
Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, for the quarter ended December 31, 2025.
07 Jan, 2026 | 01:24pm • Source: BSE
Press Release titled "Emcure expands Weight Management Therapy access with launch of Poviztra".
22 Dec, 2025 | 11:40am • Source: BSE
Intimation of schedule of Analyst/ Investor Meeting(s)
01 Dec, 2025 | 09:13pm • Source: BSE
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding search and seizure/ inspection operation conducted by Good & Service...
27 Nov, 2025 | 04:38pm • Source: BSE
Mr. Chetan Sharma (FCS:8352) has submitted his resignation from post of company Secretary and Compliance Officer & Key Managerial Personnel of the Company, with effect...
21 Nov, 2025 | 05:57pm • Source: BSE
Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation
19 Nov, 2025 | 12:29pm • Source: NSE
Investor Presentation for Investor Conferences, to be attended by officials of the Company, on November 19, 2025 and November 20, 2025
19 Nov, 2025 | 11:07am • Source: BSE